DexCom, Inc. (DXCM)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about DexCom, Inc. (DXCM)
Company Performance

Current Price

as of Oct 11, 2024

$69.21

P/E Ratio

42.86

Market Cap

$27.87B

Description

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Metrics

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerDXCM
  • Price$69.21-0.50%

Trading Information

  • Market Cap$27.87B
  • Float98.66%
  • Average Daily Volume (1m)4,085,435
  • Average Daily Volume (3m)5,758,552
  • EPS$1.71

Company

  • Revenue$3.93B
  • Rev Growth (1yr)15.26%
  • Net Income$143.50M
  • Gross Margin62.40%
  • EBITDA Margin20.92%
  • EBITDA$210.10M
  • EV$46.73B
  • EV/Revenue11.88
  • P/E42.86
  • P/S7.37
  • P/B11.45